✦ LIBER ✦

Docetaxel/cisplatin confers QOL, survival benefits in NSCLC

✍ Scribed by Greener, Mark

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel + cisplatin active in advanced

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Cisplatin improves response to docetaxel

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Biweekly docetaxel + cisplatin in stage

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Carboplatin affords superior QOL versus

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Cisplatin + vinorelbine, carboplatin + p

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 136 KB

Cisplatin-based triple chemotherapy impr

✍ Todd, Carlene 📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 123 KB